New structured care pathway aims to ease symptoms in advanced cancer

NCT ID NCT07469761

Recruiting now Symptom relief Sponsor: Augusto Caraceni Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a structured, symptom-driven care pathway improves symptom control and satisfaction for adults with advanced cancer receiving outpatient palliative care. 120 participants will be randomly assigned to either standard care or a tailored pathway that triggers specific interventions based on patient-reported symptom scores. The goal is to reduce symptom burden and distress, and improve care experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: structured palliative care pathway
What this could lead to: If it works, this could lead to better symptom control and higher satisfaction with care for people with advanced cancer.
What could go wrong: This is a small, early-stage trial (120 participants) testing a care process, not a new drug. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Frailty neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER FRAILTY OUTPATIENT PALLIATIVE CARE PALLIATIVE CARE, HEALTH SERVICES PATIENT REPORTED OUTCOME (PRO) PATIENT REPORTED OUTCOME MEASUREMENTS

Contacts and locations

Locations

IRCCS Istituto Nazionale dei Tumori, Via Venezian n1
RECRUITING

Milan, Lombardy, 20133, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.